Interim report
Page 1
Announcement to Nasdaq Copenhagen A/S and the media Nørresundby, 27 August 2026 Announcement no. 48/2026 No. of pages: 18 RTX Interim Report for Q3 and 9M 2025/26 (Reporting period: 1 October 2025 – 30 June 2026) RTX A/S • Strømmen 6 • DK-9400 Nørresundby • CVR no. 17 00 21 47
Page 2
“Revenue increased year-on-year in both Q3 and the first nine months, though Q3 performance was significantly affected by component shortages and production capacity constraints, limiting our ability to translate strong demand into revenue. At constant exchange rates, 9M revenue increased by 8.5%, reflecting stronger underlying growth than the reported figures indicate. The commercial momentum is broad-based across segments. In Healthcare, RTX continues the planned expansion of its product system deliveries under the cooperation agreement with our key customer. In Enterprise, we are seeing renewed engagement from previously less active customers, including growing interest in our next-generation solutions. ProAudio continues to show good performance, primarily on module business. The positive revenue development and improved gross margin have lifted EBITDA, despite continued investments in upskilling and organizational development, as reflected in capacity costs. Supply- side constraints currently limit output. The underlying demand remains strong and based on year-to-date performance, order visibility and current supply constraints, RTX raises guidance for the full year. ” Henrik Mørck Mogensen, CEO Strong demand supports increase in guidance despite supply constraints Financial highlights • Revenue for Q3 2025/26 increased by 3% year-on- year, reaching 151 DKKm compared to 147 DKKm in Q3 2024/25. For 9M 2025/26, revenue rose by 2% year-on-year, totalling 416 DKKm. Adjusted for currency effects revenue for the first nine months increased by 8.5%. • Gross margin reached 53.3% for Q3 2025/26, and 54.8% for 9M 2025/26. Gross margin improved compared to 9M last year due to a favourable segment and product mix, as well as higher revenue share from the ProAudio and Healthcare segments. • EBITDA reached 13 DKKm for Q3 2025/26 (Q3 2024/25: 15 DKKm) and 30 DKKm for 9M 2025/26 (22 DKKm in 9M 2024/25). Guidance RTX raises the guidance announced on 27 November 2025 for 2025/26. • Revenue 590 to 625 DKKm • EBITDA 50 to 75 DKKm • EBIT 20 to 45 DKKm Business highlights • The Enterprise segment delivered a quarter impact- ed by delivery challenges, despite continued strong demand and activity with key customers. The solid order backlog and improving customer forecasts support expectations for the full year, although im- pacted by delivery challenges on components. • Healthcare segment delivered a satisfactory result for the quarter. The period was characterized by closer collaboration with our strategic healthcare partner and successful testing activities supporting future growth opportunities. We also strengthened the commercial and operational setup during the quarter, supporting the long-term outlook. • ProAudio segment delivered a strong result for the quarter, reflecting a good momentum with key cus- tomers in the module business. • The share buy-back program initiated in August 2025 was expanded during the quarter from 20 DKKm to a total of 40 DKKm. Investor and analyst conference call 27 August, 14:00 CEST (register on Teams) 28 August 2026, 11:30 CEST (register by mail to vonh@danskebank.dk). 2 RTX interim report for Q3 and 9M 2025/26
Page 3
Group Financial Highlights and Key Ratios (non-audited) Amounts in DKK million Q3 2025/26 Q3 2024/25 9M 2025/26 9M 2024/25 FY 2024/25 Key ratios (percentage) Growth in net turnover 3.0 3.5 2.0 16.7 9.8 Gross margin 53.3 51.7 54.8 50.7 50.0 EBIT margin 3.9 5.4 1.9 0.6 1.6 Return on invested capital (3) 9.6 9.7 9.6 9.7 6.6 Return on equity (3) 3.4 4.7 3.4 4.7 3.2 Equity ratio 64.3 66.2 64.3 66.2 68.0 Employment Average number of full-time employees (4) 323 306 319 297 301 Average number of FTE employed directly (4) 297 280 293 268 273 Revenue per employee (DKK ‘000) (5) 468 480 1,303 1,371 1,818 Operating profit/loss (EBIT) per employee (DKK ‘000)(5) 18 26 25 8 29 Shares (number of shares in thousands) Average number of shares in distribution 7,842 7,978 7,880 7,978 7,975 Average number of diluted shares 7,888 7,962 7,930 7,966 7,995 Share data (DKK per share at DKK 5) Profit/loss for the period (EPS), per share (5) 0.6 0.7 0.9 0.7 1.3 Profit/loss for the period, diluted (DEPS), per share(5) 0.6 0.7 0.9 0.7 1.3 Dividends, per share - - - - - Equity value, per share 41.7 41.5 41.7 41.5 41.9 Listed price, per share 95.4 83.2 95.4 83.2 93.0 (3) Calculated over a rolling 12 months’ period. (4) Employees employed in RTX legal entities are defined as “employed directly”. Employees employed through service partner in countries where we have no legal entity, comprise the rest. (5) Not annualized. Amounts in DKK million Q3 2025/26 Q3 2024/25 9M 2025/26 9M 2024/25 FY 2024/25 Income statement items Revenue 151.3 146.9 415.7 407.3 547.1 Gross profit 80.6 76.0 227.6 206.5 273.8 EBITDA 13.4 15.0 30.1 22.2 35.5 EBITDA % 8.9% 10.2% 7.2% 5.4% 6.5% Operating profit/loss (EBIT) 5.9 7.9 8.1 2.5 8.7 Net financials -0.2 -1.2 0.6 5.1 5.2 Profit/loss before tax 5.6 6.7 8.7 7.6 14.0 Profit/loss for the period 4.4 5.2 6.8 5.9 10.5 Balance sheet items Net liquidity position (1) 135.9 118.9 135.9 118.9 153.0 Total inventory 32.9 56.5 32.9 56.5 36.8 Total assets 507.5 499.8 507.5 499.8 490.5 Equity 326.2 331.0 326.2 331.0 333.7 Liabilities 181.4 168.8 181.4 168.8 156.8 Other key figures Total development cost incurred 22.5 10.1 71.7 30.7 51.0 Capitalized own development cost 8.2 7.8 24.1 16.9 23.9 Depreciation and amortization 7.5 7.1 22.0 19.7 26.8 Cash flow from operations 22.8 19.9 31.4 40.8 82.8 Cash flow from investments -8.4 -8.4 -26.2 -22.3 -30.0 Free Cash Flow (2) 14.3 11.6 5.1 18.5 52.8 Investment in property, plant and equipment 0.3 0.4 1.7 3.1 4.5 Increase/decrease in cash and cash equivalents 7.9 9.3 -17.6 12.7 42.9 Note: The Group’s financial year runs from 1 October to 30 September. Definitions of the key ratios used are stated in the annual report for 2024/25 in the accounting policies, on page 104. (1) Equals total of cash and current asset investments. (2) Free Cash Flow = Cash flow from operations + Cash flow from investments. 3 RTX interim report for Q3 and 9M 2025/26
Page 4
With a strong focus on seamless and reliable system integration, we design, develop, and manufacture wireless IP telephony products and sub-systems. 258 DKKm 9M revenue 62% of 9M group revenue Enterprise We provide embedded wireless modules for commercial wireless audio solutions, supporting a broad range of products with superior sound quality, precise timing, and resilient, reliable transmission. 80 DKKm 9M revenue 19% of 9M group revenue ProAudio We provide the critical wireless communication infrastructure that you can embed seamlessly and reliably into a broad spectrum of high-tech medical devices, including multi-parametric patient monitoring. 78 DKKm 9M revenue 19% of 9M group revenue Healthcare Our purpose is to help people perform at their best. We provide our customers with the best possible wireless communications solutions, allowing their customers to seamlessly connect and communicate. Utilizing wireless expertise, we provide secure and reliable communication products and solutions fit for challenging environments. RTX at a Glance 4 RTX interim report for Q3 and 9M 2025/26
Page 5
Management report for Q3 and 9M 2025/26 Adjusted for currency effects, RTX achieved 8.5% year-on-year revenue growth in 9M, corresponding to reported growth of 2%. The revenue mix across segments this quarter reflected delivery timing alongside continued growth in Healthcare and ProAudio. The full year outlook for profitability is increased, supported by a strong market pull and a solid orderbook, while component shortage limits our ability to fully convert demand into deliveries. DA was below last year, as higher capacity costs from strategic hires more than offset the increase in gross profit. RTX continues to strengthen its foundation for long-term sustainable growth across Enterprise, Healthcare, and ProAudio. Revenue For 9M 2025/26, revenue rose by 8.5%, at con- stant currencies, and 2% in reported currencies year-on-year, totalling 416 DKKm, compared to 407 DKKm in 9M 2024/25. For Q3 2025/26, revenue rose by 4.3 % at constant currencies, and 3 % in reported currencies year-on-year. Enterprise segment revenue for the first nine months was lower than in 9M 2024/25, impact- ed by component shortages and constrained production capacity limiting our ability to convert demand into deliveries. The order backlog and customer forecasts improved during the quarter and continue to support our expectations for the full year. Revenue for Q3 2025/26 reached 92 DKKm (Q3 2024/25: 106 DKKm). Reve- nue for 9M 2025/26 reached 258 DKKm (9M 2024/25: 299 DKKm). ProAudio segment delivered a strong result for both the quarter and the first nine months, reflecting good momentum with key customers in the module business. RTX focuses on module sales, driving scalability through a modular prod- uct platform built on our high quality wireless audio technology. Revenue for Q3 2025/26 reached 30 DKKm (Q3 2024/25: 18 DKKm). Revenue for 9M 2025/26 reached 80 DKKm (9M 2024/25: 56 DKKm). Healthcare segment delivered a satisfactory result for the quarter, characterized by closer collaboration with our strategic healthcare partner and successful testing activities supporting future growth opportunities. The commercial and operational setup was further strengthened during the quarter, supporting the long-term outlook. Revenue for Q3 2025/26 reached 30 DKKm (Q3 2024/25: 23 DKKm). Revenue for 9M 2025/26 reached 78 DKKm (9M 2024/25: 52 DKKm). Performance Revenue grew both for the quarter and the first nine months of 2025/26, driven by ProAudio and Healthcare, which grew 42% and 51% year-on-year respectively for the nine months. This more than offset lower revenue particularly in Enterprise, where component shortages and constrained production capacity limited our ability to convert demand into deliveries during the quarter. For the first nine months, EBITDA and EBIT improved year-on-year, supported by the improved gross margin and the growth in ProAudio and Healthcare. For the quarter, EBIT- Revenue by segment DKK million Enterprise ProAudio Healthcare 9M 2025/26 9M 2024/25 Q3 2025/26 Q3 2024/25 FY 2024/25 402 106 92 299 258 56 80 407 416 52 78 67 1823 30 79 147 30 547 151 5 RTX interim report for Q3 and 9M 2025/26
Page 6
Gross profit For 9M 2025/26, gross profit rose by 10% year-on-year, totalling 228 DKKm, compared to 207 DKKm in 9M 2024/25. Gross profit for Q3 2025/26 reached 81 DKKm (Q3 2024/25: 76 DKKm). The gross margin for 9M 2025/26 reached 54.8% compared to 50.7% for 9M 2024/25, and 53.3% for Q3 2025/26 compared to 51.7% for Q3 2024/25. The gross margins are positively impacted by a favourable product mix combined with a higher revenue share from the ProAudio and Healthcare segments. Capacity costs Capacity costs (staff costs and other exter- nal expenses) amounted to 222 DKKm in 9M 2025/26 compared to 201 DKKm for 9M 2024/25. The increase is arising primarily from salary inflation, organizational adjustments and strategic hires. The average number of employees was 319 in 9M 2025/26, compared to 297 in 9M 2024/25. The increase is primarily due to the establishment of the subsidiary RTX Romania S.R.L in January 2025 and strategic hires in Healthcare and Prod- uct Management. Other external costs increased slightly in 9M 2025/26 compared to 9M 2024/25 due to general inflation. Operating profits – EBITDA and EBIT EBITDA reached 13 DKKm for Q3 2025/26 and 30 DKKm for 9M 2025/26 (Q3 2024/25: 15 DKKm, 9M 2024/25: 22 DKKm). For Q3 2025/26, EBITDA benefited from higher revenue and improved gross margins but was negatively impacted by the weaker USD, as reve- nue is primarily denominated in USD while costs are mainly incurred in DKK, EUR, and HKD. EBIT reached 6 DKKm for Q3 2025/26 and 8 DKKm for 9M 2025/26 (Q3 2024/25: 8 DKKm, 9M 2024/25: 2 DKKm). EBIT for 9M 2025/26 reflects the improved EBITDA, partly offset by higher amortization on Healthcare development projects completed during the financial year. Capitalized development projects, depreciation, and amortization During Q3 2025/26, RTX continued to invest in new product features, primarily within Enterprise and Healthcare. Own development costs of 8 DKKm were capitalized in Q3 2025/26 and 24 DKKm in 9M (Q3 2024/25: 8 DKKm, 9M 2024/25: 17 DKKm). R&D cost incurred before capitalization increased to 22.5 DKKm in Q3 2025/26 (Q3 2024/25: 10.1 DKKm), driven mainly by the strategic collaboration with a global healthcare partner on patient monitoring infrastructure, alongside continued Enterprise next-generation product investment. Depreciation and amortization amounted to 8 DKKm in Q3 2025/26 and 22 DKKm in 9M 2025/26. Gross profit and Gross margin DKK million Capacity costs DKK million EBITDA and EBITDA margin DKK million EBIT and EBIT margin DKK million Gross profit Gross margin (%) Staff costs Other external costs EBIT EBIT margin EBITDA EBITDA margin 9M 2025/26 9M 2024/25 Q3 2025/26 Q3 2024/25 FY 2024/25 196 54 58 152 171 49 51 201 22267 15 17 262 69 75 9M 2025/26 9M 2024/25 Q3 2025/26 Q3 2024/25 FY 2024/25 274 76 81 207 228 50.0% 51.7% 53.3% 50.7% 54.8% 9M 2025/26 9M 2024/25 Q3 2025/26 Q3 2024/25 FY 2024/25 36 22 30 15 13 6.5% 10.2% 8.9% 5.4% 7 .2% 9M 2025/26 9M 2024/25 Q3 2025/26 Q3 2024/25 FY 2024/25 9 2 88 6 1.6% 0.6% 1.9% 5.4% 3.9% 6 RTX interim report for Q3 and 9M 2025/26
Page 7
Cash flow from operations (CFFO) DKK million Net profit and Earnings per share Net profit before tax amounted to 5.6 DKKm in Q3 2025/26 and 8.7 DKKm for 9M (Q3 2024/25: 6.7 DKKm, 9M 2024/25: 7 .6 DKKm). For 9M 2025/26, the development is primarily driven by higher EBITDA, partly offset by signif- icantly lower financial income from hedge gains compared to 9M 2024/25. Earnings per share (EPS) reached 0.6 DKK in Q3 2025/26, compared to 0.7 DKK in Q3 2024/25. Cash flow Cash flow from operations (CFFO) in Q3 2025/26 amounted to 23 DKKm, and for 9M 2025/26 to 31 DKKm (Q3 2024/25: 20 DKKm, 9M 2024/25: 41 DKKm). For the first nine months, the development was mainly driven by working capital movements, particularly an increase in receivables, partly offset by higher trade payables. In Q3 2025/26, CFFO benefited from a reduction in receivables. The share buy-back program initiated in August 2025 was expanded during the quarter from 20 DKKm to a total of 40 DKKm, with 17 DKKm completed in 2025/26 by the end of Q3. Assets, equity and liabilities The total assets amounted to 508 DKKm at the end of 9M 2025/26 compared to 500 DKKm at the end of 9M 2024/25. Inventories were re- duced to 33 DKKm from 57 DKKm at the end of 9M 2024/25, while intangible assets increased to 125 DKKm from 92 DKKm, reflecting capital- ization of development projects, particularly in Healthcare. Total net liquidity position (total of cash and current asset investments) amounted to 136 DKKm at the end of 9M 2025/26 com- pared to 153 DKKm at the start of the fiscal year. At the end of 9M 2025/26, total equity was 326 DKKm (9M 2024/25: 331 DKKm) correspond- ing to an equity ratio of 64.3% (9M 2024/25: 66.2%). Earnings per share (EPS) DKK per share Parent company The comments above relate to the development and performance of the Group. The development and performance of the parent company, RTX A/S, are in all material aspects similar to the descriptions for the Group. Equity DKK million Net liquidity position DKK million Equity Equity ratio 9M 2025/26 9M 2024/25 Q3 2025/26 Q3 2024/25 FY 2024/25 1.3 0.7 0.6 0.7 0.9 9M 2025/26 9M 2024/25 Q3 2025/26 Q3 2024/25 FY 2024/25 83 20 23 41 31 9M 2025/26 9M 2024/25 Q3 2025/26 Q3 2024/25 FY 2024/25 153 119 136 119 136 9M 2025/26 9M 2024/25 Q3 2025/26 Q3 2024/25 FY 2024/25 334 331 326 331 326 68.0% 66.2% 64.3% 66.2% 64.3% 7 RTX interim report for Q3 and 9M 2025/26
Page 8
Outlook on profitability increased Based on the performance in 9M 2025/26, continued positive dialogue with key customers, and the current order pipeline, RTX increase its outlook on profitability for the financial year 2025/26. Revenue expectation for the full year 2025/26 is set at 590 to 625 DKKm, based on 9 months’ results, order book and pipeline. EBITDA expectation for the full year 2025/26 is set at 50 to 75 DKKm, based on revenue, gross margin expectations and capacity cost forecast. EBIT expectation for the full year 2025/26 is set at 20 to 45 DKKm. The outlook remains subject to the uncertainties inher- ent in forward-looking statements, including market developments, customer demand patterns, component availability and currency fluctuations. That said, we be- lieve the guidance remains balanced and reflects both the positive market momentum among key customers and the impact of component shortages. We expect these constraints to persist into Q4. RTX A/S Henrik Schimmell Henrik Mørck Mogensen Chair CEO Financial calendar Expected publication of financial infor- mation for the financial year 2025/26: 25 November 2026 Annual Report 2025/26 Enquiries and further information: CEO, Henrik Mørck Mogensen CFO, Mille Tram Lux tel +45 96 32 23 00 Risks and uncertainties for the 2025/26 financial year Forward-looking statements: The above statements on the Group’s future conditions, including in particular, future revenue and operating profit (EBITDA), reflect Management’s current outlook and carry some uncertainty. These statements can be affected by several risks and uncertainties, which mean that actual developments and results can be materially different from the expectations expressed directly or indirectly in this interim report. These risks and uncertainties include, but are not limited to, general economic conditions and developments, changes in demand for RTX’s products and services, competition, technological changes, fluctuations in currencies, component availability and fluctuations in sub-con- tractor supplies as well as legislative and/or regulatory changes. 8 RTX interim report for Q3 and 9M 2025/26
Page 9
Income Statement (non-audited) Statement of Comprehensive Income (non-audited) Amounts in DKK ‘000 Note Q3 2025/26 Q3 2024/25 9M 2025/26 9M 2024/25 FY 2024/25 Revenue 3 151,275 146,928 415,650 407,317 547,107 Value of own work capitalized 4 8,225 7,763 24,109 16,943 23,879 Cost of goods sold -70,650 -70,924 -188,059 -200,785 -273,315 Other external expenses -17,406 -15,102 -50,785 -48,845 -66,572 Staff costs -58,050 -53,628 -170,825 -152,436 -195,574 Operating profit/loss before depreciation and amortization (EBITDA) 13,394 15,037 30,090 22,194 35,525 Depreciation and amortization 4 -7,530 -7,139 -22,011 -19,739 -26,780 Operating profit/loss (EBIT) 5,864 7,898 8,079 2,455 8,745 Financial income 5 1,024 5,069 3,643 7,603 7,536 Financial expenses 5 -1,254 -6,274 -3,063 -2,457 -2,298 Profit/loss before tax 5,634 6,693 8,659 7,601 13,983 Tax on profit/loss -1,238 -1,472 -1,905 -1,672 -3,528 Profit/loss for the period 4,396 5,221 6,754 5,929 10,455 Earnings per share Earnings per share (DKK) 0.6 0.7 0.9 0.7 1.3 Earnings per share, diluted (DKK) 0.6 0.7 0.9 0.7 1.3 Amounts in DKK ‘000 Note Q3 2025/26 Q3 2024/25 9M 2025/26 9M 2024/25 FY 2024/25 Profit/loss for the period 4,396 5,221 6,754 5,929 10,455 Items that can be reclassified subsequently to the income statement Exchange rate adjustments of foreign subsidiaries 416 -3,977 1,147 -2,339 -2,097 Fair value adjustment relating to hedging instruments 300 494 -2,627 767 -82 Tax on hedging instruments -38 -109 606 -169 18 Fair value adjustment relating to hedging instruments reclassified to the income statement - -703 - -703 - Tax on hedging instruments reclassified - 155 - 155 - Other comprehensive income, net of tax 678 -4,140 -874 -2,289 -2,161 Comprehensive income for the period 5,074 1,081 5,880 3,640 8,294 9 RTX interim report for Q3 and 9M 2025/26
Page 10
Amounts in DKK ‘000 30.06.26 30.06.25 30.09.25 Assets Own completed development projects 51,624 29,076 26,528 Own development projects in progress 65,597 54,363 61,243 Software 61 408 321 Goodwill 7,797 7,797 7,797 Intangible assets 125,079 91,644 95,889 Right-of-use assets (lease assets) 43,335 48,721 46,811 Plant and machinery 6,181 9,766 9,241 Other fixtures, tools and equipment 2,482 3,455 3,275 Leasehold improvements 6,549 8,065 7,675 Tangible assets 58,547 70,007 67,002 Deposits 6,716 6,649 6,653 Deferred tax assets 3,010 3,902 3,676 Other non-current assets 9,726 10,551 10,329 Total non-current assets 193,352 172,202 173,220 Inventories 32,859 56,520 36,756 Trade receivables 129,127 137,049 116,366 Contract development projects in progress 2,839 2,000 2,525 Income taxes 1,001 844 129 Other receivables 4,593 5,263 2,936 Prepaid expenses 7,863 7,085 5,608 Receivables 145,423 152,241 127,564 Current asset investments in the trading portfolio 35,150 34,181 34,462 Current asset investments 35,150 34,181 34,462 Cash at bank and in hand 100,753 84,686 118,513 Total current assets 314,185 327,628 317,295 Total assets 507,537 499,830 490,515 Balance Sheet (non-audited) Amounts in DKK ‘000 30.06.26 30.06.25 30.09.25 Equity and liabilities Share capital 41,489 42,339 42,339 Share premium account 137,803 170,439 170,439 Currency adjustments 5,825 4,436 4,678 Cash flow hedging -2,150 64 -129 Retained earnings 143,197 113,751 116,343 Equity 326,164 331,029 333,670 Lease liabilities 41,038 46,998 45,141 Provisions 400 1,174 200 Deferred revenue 22,193 20,751 13,006 Other payables - - 3,602 Non-current liabilities 63,631 68,923 61,949 Lease liabilities 8,289 7,748 7,715 Prepayments received from customers 4,317 8,668 6,366 Trade payables 50,443 50,220 42,053 Contract development projects in progress 3,326 3,910 4,219 Income taxes 103 60 518 Provisions 2,500 1,326 3,700 Deferred revenue 7,259 - 6,648 Other payables 41,505 27,946 23,677 Current liabilities 117,742 99,878 94,896 Total liabilities 181,373 168,801 156,845 Total equity and liabilities 507,537 499,830 490,515 10 RTX interim report for Q3 and 9M 2025/26
Page 11
Equity Statement (non-audited) Amounts in DKK ‘000 Share capital Share premium Currency adjust- ments Cash flow hedging Retained earnings Total Equity at 1 October 2025 42,339 170,439 4,678 -129 116,343 333,670 Profit/loss for the period - - - - 6,754 6,754 Exchange rate adjustments of foreign subsidiaries - - 1,147 - - 1,147 Fair value adjustment relating to hedging instruments - - - -2,627 - -2,627 Tax on hedging instruments - - - 606 - 606 Fair value of hedging instruments reclassified to the income statement - - - - - - Tax on hedging instruments reclassified - - - - - - Other comprehensive income, net of tax - - 1,147 -2,021 - -874 Comprehensive income for the period - - 1,147 -2,021 6,754 5,880 Share-based remuneration - - - - 3,177 3,177 Current tax on equity transactions - - - - 494 494 Deferred tax on equity transactions - - - - -277 -277 Annulment of treasury shares -850 -32,636 - - 33,473 -13 Acquisition of treasury shares - - - - -16,767 -16,767 Other transactions -850 -32,636 - - 20,100 -13,386 Equity at 30 June 2026 41,489 137,803 5,825 -2,150 143,197 326,164 Amounts in DKK ‘000 Share capital Share premium Currency adjust- ments Cash flow hedging Retained earnings Total Equity at 1 October 2024 42,339 170,439 6,775 -65 103,931 323,419 Profit/loss for the period - - - - 5,929 5,929 Exchange rate adjustments of foreign subsidiaries - - -2,339 - - -2,339 Fair value adjustment relating to hedging instruments - - - 786 -19 767 Tax on hedging instruments - - - -60 -109 -169 Fair value of hedging instruments reclassified to the income statement - - - -703 - -703 Tax on hedging instruments reclassified - - - 106 49 155 Other comprehensive income, net of tax - - -2,339 129 -79 -2,289 Comprehensive income for the period - - -2,339 129 5,850 3,640 Share-based remuneration - - - - 3,966 3,966 Current tax on equity transactions - - - - - - Deferred tax on equity transactions - - - - 4 4 Annulment of treasury shares - - - - - - Acquisition of treasury shares - - - - - - Other transactions - - - - 3,970 3,970 Equity at 30 June 2025 42,339 170,439 4,436 64 113,751 331,029 The share capital of DKK 41,489,190 consists of 8,297 ,838 shares of DKK 5 (DKK 42,339,190 consisting of 8,467 ,838 shares at 30 June 2025). The Group holds 478,287 treasury shares at 30 June 2026 (489,362 shares at 30 June 2025). There are no shares carrying special rights. 11 RTX interim report for Q3 and 9M 2025/26
Page 12
Cash Flow Statement (non-audited) Amounts in DKK ‘000 Q3 2025/26 Q3 2024/25 9M 2025/26 9M 2024/25 FY 2024/25 Repayment of lease liabilities -2,077 -2,281 -5,992 -5,861 -7,751 Acquisition of treasury shares -4,320 - -16,767 - -2,147 Cash flow from financing activities -6,397 -2,281 -22,759 -5,861 -9,898 Increase/decrease in cash and cash equivalents 7,944 9,294 -17,620 12,678 42,876 Exchange rate adjustments on cash -167 975 -140 -1,979 1,650 Cash and cash equivalents at the beginning of the period, net 92,976 74,417 118,513 73,987 73,987 Cash and cash equivalents at the end of the period, net 100,753 84,686 100,753 84,686 118,513 Cash and cash equivalents at the end of the period, net are composed as follows: Cash at bank and in hand 100,753 84,686 100,753 84,686 118,513 Cash and cash equivalents at the end of the period, net 100,753 84,686 100,753 84,686 118,513 Amounts in DKK ‘000 Q3 2025/26 Q3 2024/25 9M 2025/26 9M 2024/25 FY 2024/25 Operating profit/loss (EBIT) 5,864 7,898 8,079 2,455 8,745 Reversal of items with no effects on cash flow Depreciation and amortization 7,530 7,139 22,011 19,739 26,780 Other items with no effects on cash flow -2,791 1,858 -3,937 8,917 12,879 Change in working capital Change in inventories -3,167 14,540 5,327 15,591 29,265 Change in receivables 16,155 -8,843 -19,269 -13,320 10,514 Change in trade payables, etc. 396 1,191 19,674 2,215 -8,612 Financial income received 451 -2,244 4,247 8,452 7,326 Financial expenses paid -862 -1,201 -3,063 -2,457 -3,158 Income taxes paid -811 -393 -1,703 -765 -944 Cash flow from operating activities 22,765 19,945 31,366 40,827 82,795 Investments in own development projects -8,161 -7,989 -24,039 -17,851 -24,731 Acquisition of property, plant and equipment -250 -440 -1,731 -3,103 -4,478 Sale of tangible assets - - - - 147 Deposits on leaseholds -13 59 -63 -44 -48 Acquisition of current asset investments in the trading portfolio - - -394 -1,290 -911 Cash flow from investments -8,424 -8,370 -26,227 -22,288 -30,021 12 RTX interim report for Q3 and 9M 2025/26
Page 13
1 Accounting policies The interim report is presented in accordance with IAS 34 “Interim Financial Reporting” as adopted by the EU and additional Danish disclosure requirements for interim reporting of listed companies. An interim report has not been prepared for the Parent. The accounting policies applied in this interim report are consistent with those applied in the Compa- ny’s 2024/25 annual report which was presented in accordance with International Financial Reporting Standards (IFRS) as adopted by the EU and additional Danish disclosure requirements for annual reports of listed companies. We refer to the 2024/25 annual report for a more detailed description of the accounting policies. The applied accounting policies are unchanged compared to the annual report for 2024/25. New or amended standards and interpretations becoming effective for the financial year 2025/26 have no material impact on the interim report. 2 Estimates and assumptions The preparation of interim reports requires management to make financial estimates and assumptions that affect the application of accounting policy and recognized assets, liabilities, income and expenses. Actual results might be different from these estimates. The material estimates that management make when applying the accounting principles of the Group and the material uncertainty connected with these estimates and assumptions are unchanged in the preparation of the interim report compared to the preparation of the annual report as per 30 September 2025. 3 Segment information In accordance with internal reporting, RTX reports on the three target market segments; Enterprise, ProAudio and Healthcare. Costs are reported by allocating costs directly attributable to the three reportable market segments whereas common functions costs which cannot be allocated directly to a segment (primarily other external expenses, staff costs and depreciations related to IT , finance, overall management, joint facilities, joint technology projects, and supply chain management) are allocated based on allocation keys related to relative revenue split in accordance with internal reporting. For a presentation of the events within the segments in the financial year and the development compared to 2024/25, please refer to the Management Review. Notes 13 RTX interim report for Q3 and 9M 2025/26
Page 14
3 Segment information continued 2025/26 2024/25 Amounts in DKK ‘000 Q1 Q2 Q3 Q4 9M Q1 Q2 Q3 Q4 9M Full year Revenue Enterprise 61,537 104,531 91,589 - 257,657 78,559 114,373 106,440 102,275 299,372 401,647 ProAudio 27,001 23,117 29,540 - 79,658 17,442 21,244 17,506 22,370 56,192 78,562 Healthcare 19,240 28,949 30,146 - 78,335 4,524 24,247 22,982 15,145 51,753 66,898 Total Revenue, RTX Group 107,778 156,597 151,275 - 415,650 100,525 159,864 146,928 139,790 407,317 547,107 EBITDA Enterprise -13,227 3,646 -5,877 - -15,458 462 8,923 11,410 10,265 20,795 31,060 ProAudio 3,668 4,493 12,156 - 20,317 -4,864 -4,727 -6,768 -2,068 -16,359 -18,427 Healthcare 5,632 12,484 7,115 - 25,231 -5,005 12,368 10,395 5,134 17,758 22,892 Total EBITDA, RTX Group -3,927 20,623 13,394 - 30,090 -9,407 16,564 15,037 13,331 22,194 35,525 Revenue, geographical segment Denmark 15,354 12,386 9,459 - 37,199 11,630 36,494 26,456 21,742 74,580 96,322 France 26,989 19,642 22,141 - 68,772 21,013 18,343 24,558 25,923 63,914 89,837 Great Britain 2,191 14,359 14,088 - 30,638 14,310 17,153 13,793 13,816 45,256 59,072 Other Europe 21,145 23,784 18,841 - 63,770 13,881 33,729 28,132 22,969 75,742 98,711 USA 17,326 47,662 32,987 - 97,975 22,332 35,452 34,665 32,059 92,449 124,508 Other Asia and Pacific 24,276 38,672 53,046 - 115,994 15,996 17,227 17,774 23,104 50,997 74,101 Other 497 92 713 - 1,302 1,363 1,466 1,550 177 4,379 4,556 Total Revenue, RTX Group 107,778 156,597 151,275 - 415,650 100,525 159,864 146,928 139,790 407,317 547,107 In accordance with internal reporting, RTX reports on three target market segments: Enterprise, ProAudio and Healthcare. Costs directly attributable to the three reportable market segments are allocated accordingly. The majority of RTX’s capacity costs are not allocated directly to a segment but are allocated based on the segments’ expected relative shares of revenue. This reflects RTX’s platform-based operating and development model, under which resources, technologies and capabilities are shared across segments and therefore are not clearly attributed to individual segments. For a presentation of events within the segments during the financial year and developments compared with 2024/25, please refer to the Management Review. Notes 14 RTX interim report for Q3 and 9M 2025/26
Page 15
Notes 4 Development costs Amounts in DKK ‘000 Q3 2025/26 Q3 2024/25 9M 2025/26 9M 2024/25 FY 2024/25 Research and development cost incurred before capitalization(1) 22,491 10,055 71,719 30,661 50,970 Capitalization regarding strategic collaboration(1) -3,259 - -14,482 - - Value of own work capitalized(2) -8,142 -7,719 -23,868 -16,698 -23,506 Total amortization on development projects 3,534 2,601 9,072 6,230 8,778 Development costs recognized in the profit/loss account 14,624 4,937 42,441 20,193 36,242 (1) Research and development cost incurred before capitalization of 22.5 DKKm in Q3 2025/26 includes additional investment in strategic collaboration with a large global Healthcare company regarding a new generation of wireless infrastructure for patient monitoring solutions for the hospital healthcare sector. The investment in 9M 2025/26 relates to deferred revenue of 14.5 DKKm, of which 11.2 DKKm was deferred in Q1 2025/26 and is recognized as income over 5 years starting Q2 2025/26, and 3.3 DKKm was deferred in Q3 2025/26 and is recognized as income over 5 years starting Q3 2025/26. (2) Total value of own work capitalized of 8.2 DKKm in Q3 2025/26 according to the income statement includes own tangible assets of 0.2 DKKm (Q3 2024/25: 0.0 DKKm). 5 Financial items Amounts in DKK ‘000 Q3 2025/26 Q3 2024/25 9M 2025/26 9M 2024/25 FY 2024/25 Exchange rate gains (net) - - 1,499 574 210 Fair value adjustments of investments in trading portfolio 622 298 293 - - Gain on hedging instruments (net) - 4,559 - 4,445 4,799 Other financial income 402 212 1,851 2,584 2,527 Total financial income 1,024 5,069 3,643 7,603 7,536 Exchange rate losses (net) 392 5,766 - - - Fair value adjustments of investment in trading portfolio - - - 807 147 Financing element, IFRS 16 405 483 1,274 1,569 2,036 Loss on hedging instruments (net) 430 - 1,681 - - Other financial costs 27 25 108 81 115 Total financial expenses 1,254 6,274 3,063 2,457 2,298 15 RTX interim report for Q3 and 9M 2025/26
Page 16
Notes 6 Fair value hierarchy for financial instruments The below indicates the classification of the financial instruments divided in accordance with the fair value hierarchy: • Listed prices in an active market for the same type of instrument (level 1) • Listed prices in an active market for similar assets or liabilities or other valuation methods, where all significant input is based on observable market data (level 2) • Valuation methods, where any significant input is not based on observable market data (level 3) Amounts in DKK ‘000 Level 1 Level 2 Level 3 Total Financial instruments (hedging), assets - - - - Financial instruments (hedging), liability - -2,756 - -2,756 Bonds listed on the stock exchange, in the trading portfolio 35,150 - - 35,150 Financial net assets at fair value at 30 June 2026 35,150 -2,756 - 32,394 Financial instruments (hedging), assets - 2,736 - 2,736 Financial instruments (hedging), liability - - - - Bonds listed on the stock exchange, in the trading portfolio 34,181 - - 34,181 Financial net assets at fair value at 30 June 2025 34,181 2,736 - 36,917 Financial hedging instruments comprise standard foreign exchange forward contracts with the USD/DKK exchange rate as the main element affecting the fair value of the contracts. 16 RTX interim report for Q3 and 9M 2025/26
Page 17
Management’s Statement The Board of Directors and the Executive Board have today considered and adopted the interim report of RTX A/S for the first nine months of the financial year 2025/26 (covering the period 1 October 2025 to 30 June 2026). The interim report is prepared in accordance with IAS 34, Interim Financial Reporting, as adopted by the EU and additional Danish disclosure require- ments for the interim reporting of listed companies. The interim report has not been audited or reviewed by the Company’s auditor. We consider the applied accounting policies appropriate for the interim report to provide, in our opinion, a true and fair view of the Group’s assets, liabilities and financial position as of 30 June 2026 and of its financial per- formance and cash flow for the first 9M of the financial year 2025/26. We consider Management’s review to give a true and fair view of the Group’s activities and finances, profit/loss for the period and the Group’s financial position as a whole, as well as a true and fair description of the most material risks and uncertainties facing the Group. Nørresundby, 27 August 2026 Executive Board Henrik Mørck Mogensen Mille Tram Lux CEO CFO Board of Directors Henrik Schimmell Katja Millard Jesper Mailind Chair of the Board Deputy Chair Board member Mogens Vedel Hestbæk Gitte Schjøtz Carsten Drachmann Board member Board member Board member Kevin Harritsø Camilla Munk Kurt Heick Rasmussen Employee Representative Employee Representative Employee Representative 17 RTX interim report for Q3 and 9M 2025/26
Page 18
Design and production: Noted RTX A/S Strømmen 6 9400 Nørresundby Denmark rtx.dk